FirsthandHealth
medRxiv PreprintsInternational15 November 2026

Estimating the Economic Burden of Typhoid Fever in Ibadan, Nigeria

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: Evidence on the economic burden of typhoid fever remains limited in sub-Saharan Africa. This study estimated the costs associated with typhoid fever and related invasive Salmonella infections in Ibadan, Nigeria. Methods: A field-based cost-of-illness study was conducted at six healthcare facilities between 2022 and 2025. Patients with Salmonella enterica serovar Typhi (S. Typhi), Salmonella enterica serovar Paratyphi (S. Paratyphi), invasive non-typhoidal Salmonella (iNTS), or typhoid gastrointestinal perforation (special cases) were enrolled, with malaria patients serving as contr
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.